Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.18M Buy
556,800
+56,800
+11% +$723K ﹤0.01% 3840
2025
Q4
$8.2M Buy
500,000
+422,500
+545% +$6.58M ﹤0.01% 3504
2025
Q3
$1.04M Sell
77,500
-257,302
-77% -$3.04M ﹤0.01% 5546
2025
Q2
$4.29M Buy
334,802
+88,608
+36% +$1.06M ﹤0.01% 4035
2025
Q1
$2.54M Sell
246,194
-25,694
-9% -$331K ﹤0.01% 4491
2024
Q4
$3.46M Buy
271,888
+75,000
+38% +$991K ﹤0.01% 4194
2024
Q3
$2.52M Buy
196,888
+21,888
+13% +$268K ﹤0.01% 3765
2024
Q2
$2.22M Buy
+175,000
New +$3.03M ﹤0.01% 3673
2023
Q4
Sell
-78,300
Closed -$1.34M 9746
2023
Q3
$1.34M Buy
+78,300
New +$1.3M ﹤0.01% 3834
2023
Q2
Sell
-330,000
Closed -$5.79M 9452
2023
Q1
$5.79M Buy
+330,000
New +$4.99M ﹤0.01% 2375
2022
Q4
Sell
-220,000
Closed -$2.77M 11028
2022
Q3
$2.77M Hold
220,000
﹤0.01% 2867
2022
Q2
$4M Buy
220,000
+180,000
+450% +$3.37M ﹤0.01% 2558
2022
Q1
$864K Buy
+40,000
New +$1.35M ﹤0.01% 4249

Other funds holding PATH

UBS Group's PATH Position: Q1 2026 in Review

UBS Group increased its UiPath (PATH) stake by 97% in Q1 2026, buying an estimated $59M and bringing the position to 9,403,093 shares worth $104M. The position accounts for 0.02% of the portfolio, ranked #1022.

UBS Group first reported a position in PATH in Q2 2021 and has held it in 20 quarters since. The position peaked at $471M in Q2 2025. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • UBS Group held 9,403,093 shares of UiPath worth $104M as of Q1 2026.
  • UBS Group bought 4,633,195 UiPath shares in Q1 2026, an estimated $59M.
  • UiPath made up 0.02% of UBS Group's portfolio in Q1 2026, its #1022 holding.
  • UBS Group first reported a position in UiPath in Q2 2021 and has held it in 20 quarters since.
  • UBS Group's UiPath position peaked at $471M in Q2 2025.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.